Lowe Brockenbrough & CO Inc Gilead Sciences, Inc. Transaction History

Lowe Brockenbrough & CO Inc

$1.47 Billion
Q1 2024

A detailed history of Lowe Brockenbrough & CO Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 7,410 shares of GILD stock, worth $506,844. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,410

Previous 9,416 21.3%

Holding current value

$506,844

Previous $762,000 28.87%

% of portfolio

0.04%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $143,589 - $175,103	-2,006 Reduced 21.3%	7,410 $542,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $144,195 - $163,521	1,968 Added 26.42%	9,416 $762,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $221,820 - $242,010	-3,000 Reduced 28.71%	7,448 $558,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $2,937 - $3,347	38 Added 0.37%	10,448 $866,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $31,160 - $44,735	500 Added 5.05%	10,410 $893,000

Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $9,754 - $10,986	-169 Reduced 1.68%	9,910 $613,000
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $22,299 - $27,943	-385 Reduced 3.68%	10,079 $599,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $67,690 - $73,030	-1,000 Reduced 8.72%	10,464 $731,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $1,740 - $1,985	29 Added 0.25%	11,464 $741,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $4,248 - $4,841	-75 Reduced 0.65%	11,435 $666,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $2,794 - $3,513	-45 Reduced 0.39%	11,510 $727,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $27,850 - $32,340	-385 Reduced 3.22%	11,555 $889,000
Q1 2020 May 21, 2020	SELL	$62.63 - $80.22 $4.37 Million - $5.6 Million	-69,752 Reduced 85.38%	11,940 $893,000
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $146,347 - $160,977	2,375 Added 2.99%	81,692 $5.31 Million
Q3 2019 Nov 21, 2019	BUY	$62.51 - $69.0 $149,836 - $165,393	2,397 Added 3.12%	79,317 $5.03 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $12,992 - $14,569	210 Added 0.27%	76,920 $5.2 Million
Q1 2019 May 21, 2019	BUY	$62.53 - $70.05 $1,063 - $1,190	17 Added 0.02%	76,710 $4.99 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $878,132 - $1.15 Million	-14,505 Reduced 15.9%	76,693 $4.8 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $12,474 - $13,811	175 Added 0.19%	91,198 $7.04 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $15,571 - $18,163	240 Added 0.26%	91,023 $6.45 Million
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $25,858 - $31,524	355 Added 0.39%	90,783 $6.84 Million
Q4 2017 Jan 30, 2018	BUY	$71.15 - $83.52 $5.07 Million - $5.95 Million	71,233 Added 371.1%	90,428 $6.48 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.38 Million - $1.64 Million	19,195	19,195 $1.56 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Account

Lowe Brockenbrough & CO Inc Gilead Sciences, Inc. Transaction History